Valuation: Lamdong Pharmaceutical

Market Cap 14TCr 56.24L 49.03L 46.15L 41.82L 79.31L 53Cr 79.31L 5.52Cr 2.13Cr 27Cr 2.09Cr 2.03Cr 87Cr P/E 2024
18.7x
P/E 2025 5.47x
Enterprise Value 18TCr 70.34L 61.32L 57.71L 52.3L 99.19L 67Cr 99.19L 6.91Cr 2.67Cr 34Cr 2.62Cr 2.54Cr 109.26Cr EV / Sales 2024
0.77x
EV / Sales 2025 0.76x
Free-Float
60.32%
Yield 2024 *
-
Yield 2025 -
28/07 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
23/04 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
27/01 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
23/25/23 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
18/25/18 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
26/25/26 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/25/24 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
28/24/28 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
19/24/19 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
16/24/16 Lamdong Pharmaceutical Joint Stock Company acquired 6.02% stake in Big Invest Group Joint Stock Company. CI
16/24/16 An undisclosed buyer acquired 5.27% stake in Big Invest Group Joint Stock Company from Lamdong Pharmaceutical Joint Stock Company. CI
17/24/17 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
10/24/10 Lamdong Pharmaceutical Joint Stock Company announced that it expects to receive VND 90.75 billion in funding CI
1 week-1.28%
Current month-1.28%
1 month+8.45%
3 months-9.41%
6 months-4.94%
Current year-30.63%
1 week 7,400
Extreme 7400
7,800
1 month 7,100
Extreme 7100
8,000
Current year 7,000
Extreme 7000
11,100
1 year 7,000
Extreme 7000
12,800
3 years 7,000
Extreme 7000
25,000
5 years 4,200
Extreme 4200
55,000
10 years 4,200
Extreme 4200
55,000
Manager TitleAgeSince
Chief Executive Officer - 05/07/2021
Director of Finance/CFO - 24/09/2020
Comptroller/Controller/Auditor 48 -
Director TitleAgeSince
Chairman 75 28/07/2010
Chairman - 05/07/2021
Director/Board Member - 26/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.28%-32.46%-39.84% 55.51L
+0.11%+2.76%+63.52%+115.51% 1,05500Cr
+0.27%+0.73%+51.33%+73.10% 65TCr
+0.73%+0.88%+20.70%+73.89% 47TCr
-1.36%-0.39%+40.20%+41.03% 35TCr
+1.34%+5.47%+23.37%+31.30% 27TCr
-0.48%-0.06%+13.56%+12.36% 26TCr
+0.85%+8.42%+53.17%+55.45% 22TCr
+0.85%+1.40%+35.78%+101.47% 19TCr
-0.30%-10.41%-27.62%-61.04% 17TCr
Average +0.20%+0.54%+24.16%+40.32% 36.38TCr
Weighted average by Cap. +0.19%+1.32%+40.69%+69.05%

Financials

2024 2025
Net sales 22TCr 85L 74.11L 69.75L 63.21L 1.2Cr 81Cr 1.2Cr 8.35Cr 3.23Cr 41Cr 3.16Cr 3.07Cr 132.04Cr 24TCr 95.12L 82.93L 78.05L 70.73L 1.34Cr 90Cr 1.34Cr 9.34Cr 3.61Cr 46Cr 3.54Cr 3.44Cr 147.76Cr
Net income 691.9Cr 3L 2L 2L 2L 4L 2.56Cr 4L 26.5L 10.24L 1.3Cr 10.03L 10L 4.19Cr 2.86TCr 11.14L 10L 9L 8L 15.71L 11Cr 15.71L 1.09Cr 42.27L 5.39Cr 41.41L 40.27L 17Cr
Net Debt 3.79TCr 14.77L 12.88L 12.12L 10.98L 20.83L 14Cr 20.83L 1.45Cr 56.05L 7.14Cr 54.91L 53.4L 23Cr 3.61TCr 14.1L 12.29L 11.57L 10.48L 19.88L 13Cr 19.88L 1.38Cr 53.49L 6.82Cr 52.41L 50.96L 22Cr
Logo Lamdong Pharmaceutical
Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
Employees
261
Date Price Change Volume
28/26/28 ₫7,700.00 0.00% 2,000
25/26/25 ₫7,700.00 -1.28% 63,200
24/26/24 ₫7,800.00 0.00% 45,601
23/26/23 ₫7,800.00 0.00% 26,800
22/26/22 ₫7,800.00 0.00% 10,558